NBY - NovaBay Pharmaceuticals, Inc.
0.58
0.010 1.690%
Share volume: 12,284
Last Updated: 04-25-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.10%
PREVIOUS CLOSE
CHG
CHG%
$0.57
0.01
0.02%
Summary score
34%
Profitability
25%
Dept financing
24%
Liquidity
75%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-82.37%
Return on assets
-16.81%
Return on sales
-78.56%
Return on invested capital
84.98%
Total debt ratio
69.14%
Debt ratio change over timeo
0%
Current Ratio
2.49%
Quick Ratio
2.36%
Cash Position Ratio
1.31%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-92.64%
Return on assets
-13.98%
Return on sales
-86.3%
Return on invested capital
72.69%
Total debt ratio
91.9%
Debt ratio change over timeo
0%
Current Ratio
1.96%
Quick Ratio
1.85%
Cash Position Ratio
1.44%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-455.95%
Return on assets
-8.07%
Return on sales
-26.88%
Return on invested capital
152.6%
Total debt ratio
92.59%
Debt ratio change over time
0%
Current Ratio
2.77%
Quick Ratio
2.62%
Cash Position Ratio
2.04%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NBY | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -82.37% | 17.45% | 4.69% | 19.89% |
| Return on assets | -16.81% | 3.37% | 3.35% | 11.41% |
| Return on sales | -78.56% | 23.96% | 25.96% | 42.05% |
| Return on invested capital | 84.98% | 5.2% | 4.37% | -272.99% |
| Profitability | 25% | 45% | 30% | 75% |
| Total debt ratio | 69.14% | 77% | 57.66% | 53.92% |
| Debt ratio change over time | 0% | 0% | 10.55% | 0% |
| Dept financing | 22% | 25% | 44% | 18% |
| Current Ratio | 1.96% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 1.85% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 1.44% | 0.17% | 0.53% | 0.31% |
| Liquididy | 75% | 31% | 42% | 27% |
| Short-term ratios | NBY | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -92.64% | 44.06% | 6.24% | 17.3% |
| Return on assets | -13.98% | 3.88% | 3.22% | 9.33% |
| Return on sales | -86.3% | 27.04% | 24.93% | 40.02% |
| Return on invested capital | 72.69% | 9.69% | 4.96% | -224.06% |
| Profitability | 25% | 56% | 29% | 60% |
| Total debt ratio | 91.9% | 91.8% | 61.39% | 55.88% |
| Debt ratio change over time | 0% | 0% | 12.93% | 0% |
| Dept financing | 25% | 25% | 42% | 15% |
| Current Ratio | 1.96% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 1.85% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 1.44% | 0.17% | 0.53% | 0.31% |
| Liquididy | 75% | 30% | 39% | 29% |
